Skip to content

NEFROLOGIE IEPER

Active Risk: very low
Private limited companyfounded 2019active for 7 yearsBriekestraat 12, 8900 Ieper, Belgium45 active companies are registered at this addressKBO/BCE: BE 0724.846.158
Summary

NEFROLOGIE IEPER has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €19,350. Equity remains stable across the filed financial years (±0% per year). Its solvency ranks better than 5% of 3,001 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow ReportCompare
NEFROLOGIE IEPERActive
Risk analysis ReportCompare

Overview

Activity
Specialist medical practice
NACE 86220
1 site
Size
€3.0mtotal assets 2025
Equity
€19,350
Turnover not published (abbreviated format)
Financial health
Bankruptcy probabilitywithin 12 months
< 0.1%
Too few figures to score
Structure
Largest shareholder
DR.PAULIEN VAN ACKER, NEFROLOGIE · 16.67%
Accounts 25 days early2 of 5 deeds read
Signalsraises riskEquity €19,350 (0.6% of total assets)Weak solvency vs sectorlowers riskSector: Human health activities (NACE 86)Size: total assets €3.0mFigures for financial year 2025 (filed 06-07-2026)neutralLatest accounts filed on timeShow the evidence

Bankruptcy probability

No current score
Insufficient figures
A score requires measurable solvency, liquidity and profitability. Missing figures are not a judgement about the company.
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (1,074 companies, NACE 86, small)
Last 24 months 11-2024: 0.2% 12-2024: 0.2%● unchanged vs 11-2024 01-2025: 0.2%● unchanged vs 12-2024 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.3%▲ +0.1 percentage points vs 02-2025 04-2025: 0.3%● unchanged vs 03-2025 05-2025: 0.3%● unchanged vs 04-2025 06-2025: 0.3%● unchanged vs 05-2025 07-2025: 0.3%● unchanged vs 06-2025highest value 08-2025: < 0.1%▼ -0.3 percentage points vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025lowest value 10-2025: < 0.1%● unchanged vs 09-2025lowest value 11-2025: < 0.1%● unchanged vs 10-2025lowest value 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: 0.1%▲ +0.1 percentage points vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: < 0.1%▼ -0.1 percentage points vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €3.0m
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 06-07-2026)
NBB · annual accounts
raises risk · Equity €19,350 (0.6% of total assets)
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 5% of 3001 sector peers (2025).
NBB · sector comparison
Position among 3001 sector peers
Solvency
better than 5%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 06-07-2026, 25 days ahead of the deadline.
NBB · 7 filings
Deviation from the deadline
2025
25 days early
2024
8 days early
2023
13 days early
2022
14 days early
2021
18 days early
2020
24 days early
2019
14 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 17 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 17 July (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
23-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Annual accounts filedfinancial year 2024 · abbreviated…
  3. Appointment: DR. KELLY DE SCHUYTER (director)Permanent representative: Kelly DE SCHUYTER

Key points

  • Caution: Among the weakest 6% on solvencysector median 59.0% · 3,001 companies 0.6% View
  • Positive: Always filed on timeaccounts within the deadline every year 7 years View
  • Board2 directors in office 2 View

By topic

Financials

Financial year
2025
Total assets
€3.0m
Solvency
0.6%
Liquidity
1.01
Total assets▲ 7.6%
20192025
Go to Financials

Board & ownership

Board
2 members
Largest shareholder
DR.PAULIEN VAN ACKER, NEFROLOGIE · 16.67%
  • DR.PAULIEN VAN ACKER, NEFROLOGIEDirector
  • Dr. Kelly De SchuyterDirector
Go to Board & ownership

Timeline

Events
9
Since
2020
Next accounts
by 31-07-2027
  1. 18-07-2024Annual accounts filed
  2. 27-05-2024Appointment: DR. PAULIEN VAN ACKER, NEFROLOGIE (director)
  3. 17-07-2023Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
12-04-2019
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure